Anxiety trials recruiting in Connecticut

All Anxiety trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
  NCT07065240 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: Cromwell
• Aerobic Exercise and Obsessive-Compulsive Disorder Symptoms
  NCT07103902 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · Connecticut: New Haven
• Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
  NCT05810259 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: New Haven
• Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
  NCT04131829 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: New Haven
• Cannabidiol Effects on Learning and Anxiety
  NCT05283382 · Phase: Early Phase 1 · Ages: 18 Years to 50 Years · Sex: All (male and female) · Connecticut: Storrs
• Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
  NCT07420101 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Hartford
• Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
  NCT05207085 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: New Haven
• External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
  NCT06788977 · Phase: Not specified · Ages: 18 Years to 44 Years · Sex: Female · Connecticut: Darien
• Music for Pain and Dementia
  NCT07602283 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• Open-Label Psilocybin Study in Transdiagnostic Population
  NCT06442423 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Parent-Based Treatment for Adolescent Anxiety
  NCT07219992 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 17 Years · Sex: All (male and female) · Connecticut: New Haven
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
  NCT06701903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Farmington
• Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
  NCT06846320 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: Cromwell
• Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder
  NCT06834217 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Connecticut: New Haven